Furthermore, COVID-19 could have revealed a pre-existing autoimmune condition/predisposition: the woman might have had previously DM-like skin rash, and SARS-CoV-2 infection could have unveiled overt disease by eliciting a strong IFN signature. Here, IFNA1 is linked to dermatomyositis.